Peptonic Medical is a biomedical company that conducts research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to offer treatments for women-specific diseases and medical conditions. For example, hormone-free products are being developed for the treatment of vaginal atrophy and vaginal dryness. Peptonic Medical has its headquarters in Bromma.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Maida Vale Capital AB | 31,56 | 31,56 | 2025-12-23 |
| Nordnet Pensionsförsäkring | 5,49 | 5,49 | 2025-12-23 |
| Heli Kurjanen | 3,71 | 3,71 | 2023-12-31 |
| Henrik Hahn | 2,68 | 2,68 | 2025-12-23 |
| Petter Eriksson | 2,29 | 2,29 | 2025-12-23 |
| Avanza Pension | 2,03 | 2,03 | 2025-12-23 |
| Mika Kurjanen | 1,93 | 1,93 | 2023-12-31 |
| Quartier Latin AB | 1,90 | 1,90 | 2025-12-23 |
| Vidarstiftelsen | 1,82 | 1,82 | 2025-12-23 |
| Nordnet Livsforsikring AS | 1,71 | 1,71 | 2025-12-23 |
2026-05-27 Interim Report 2026-Q1
2026-06-10 Annual General Meeting 2025
2026-08-19 Interim Report 2026-Q2
2026-11-10 Interim Report 2026-Q3
2027-02-23 Year End Report 2026